Literature DB >> 16301589

Improving long-term outcomes for patients with liver metastases from colorectal cancer.

Geoffrey Chong, David Cunningham.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16301589     DOI： 10.1200/JCO.2005.04.4669

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres.

Authors:  Neha Bhooshan; Navesh K Sharma; Shahed Badiyan; Adeel Kaiser; Fred M Moeslein; Young Kwok; Pradip P Amin; Svetlana Kudryasheva; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2016-12

2.  Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.

Authors:  Karianne G Fleten; Kine M Bakke; Gunhild M Mælandsmo; Andreas Abildgaard; Kathrine Røe Redalen; Kjersti Flatmark
Journal:  Clin Exp Metastasis       Date:  2016-11-03       Impact factor: 5.150

Review 3.  Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.

Authors:  Muhammad Wasif Saif
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

4.  Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.

Authors:  Federica Zoratto; Luigi Rossi; Angelo Zullo; Anselmo Papa; Eleonora Zaccarelli; Luigi Tomao; Erika Giordani; Maria Colonna; Giovanni Baiano; Silverio Tomao
Journal:  Onco Targets Ther       Date:  2012-09-24       Impact factor: 4.147

Review 5.  Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases.

Authors:  Luigi Rossi; Angelo Zullo; Federica Zoratto; Anselmo Papa; Martina Strudel; Maria Colonna; Silverio Tomao
Journal:  Oncol Rev       Date:  2012-06-14

Review 6.  Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.

Authors:  Mihir Raval; Dinesh Bande; Anil K Pillai; Lawrence S Blaszkowsky; Suvranu Ganguli; Muhammad S Beg; Sanjeeva P Kalva
Journal:  Front Oncol       Date:  2014-07-25       Impact factor: 6.244

Review 7.  Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.

Authors:  Pilar García-Alfonso; Ana Ferrer; Silvia Gil; Rosario Dueñas; María Teresa Pérez; Raquel Molina; Jaume Capdevila; María José Safont; Carmen Castañón; Juana María Cano; Ricardo Lara
Journal:  Target Oncol       Date:  2015-03-11       Impact factor: 4.493

8.  Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.

Authors:  Hirozumi Sawai; Akira Yasuda; Nobuo Ochi; Jiachi Ma; Yoichi Matsuo; Takehiro Wakasugi; Hiroki Takahashi; Hitoshi Funahashi; Mikinori Sato; Hiromitsu Takeyama
Journal:  BMC Gastroenterol       Date:  2008-11-26       Impact factor: 3.067

9.  First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).

Authors:  K Eichler; S Zangos; M G Mack; R Hammerstingl; T Gruber-Rouh; C Gallus; T J Vogl
Journal:  Int J Oncol       Date:  2012-07-25       Impact factor: 5.650

10.  Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.

Authors:  Yun Liu; Guanghui Wang; Zhonglin Liang; Zubing Mei; Tingyu Wu; Ang Cui; Chenying Liu; Long Cui
Journal:  Thorac Cancer       Date:  2018-05-15       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.